2014-01-29 07:54:01 - H1N1 Vaccines: A Global Strategic Business Report - a new market research report on companiesandmarkets.com
The global H1N1 Vaccines market is forecast to decline to US$273 million by the year 2018, as a result of the waning occurrences of the Influenza Type A H1N1 virus in the post-pandemic phase.
Worldwide influenza vaccine sales skyrocketed in the year 2009 with the introduction of vaccines to tackle the Influenza A (H1N1) pandemic virus. However, the momentum provided by the dreaded Swine Flu, ran out of steam by August 2010, with the World Health Organization (WHO) officially declaring the disease to have entered the post-pandemic stage. Nevertheless, the WHO continues to monitor outbreaks and prevalence of the H1N1 flu virus. Small outbreaks in Influenza A (H1N1)pdm09 virus were reported in certain countries of Asia, Africa, Europe, South America, as
well as Central America in the post-pandemic phase. The Influenza A (H1N1)pdm09 virus is considered responsible for all the seasonal activity of (H1N1) A viruses between September 2012 and January 2013.
The recent advancements in cell-culture and recombinant technologies are boosting the speed and efficiency of the vaccine production processes. However, the traditional egg-based production method remains the most widely used method for vaccine preparation. This method however requires larger time-frames and thereby result in inadequate supply of the necessary vaccines in case of a sudden pandemic attack. New strains of viruses resulting from antigenic shift of the A/California/7/2009 (H1N1)pdm09 virus, usually occurring when the virus is being passed on from animal to animal or a human being, also stresses the need to develop more effective vaccines. However, manufacturers face a daunting challenge in the form of the huge costs involved in vaccine development, clinical trials, regulatory approval, mass production, and commercialization.
North America accounts for the largest share of H1N1 vaccine sales worldwide, as stated by the new market research report on H1N1 Vaccines. Rapid growth in birth cohorts in developing countries, coupled with the improvement in access to public and private healthcare and increased spending, entail a growing demand for vaccines in the developing world. Notably, the 2009 H1N1 pandemic resulted in widespread panic in China and India, partly due to the respective government´s unpreparedness to handle the disease outbreak. The governments in these countries are expected to continue domestic production and stockpiling of reserve H1N1 vaccine doses in the near term. Increasing public awareness about influenza vaccines, coupled with the need to safeguard the population in the event of a future outbreak, will continue to drive sales of H1N1 vaccines. Global Industry Analysts Â©
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.